. Ubiquitin tagging of membranebound cytoplasmic and nuclear proteins identifies these molecules as a target for degradation by the proteasome and can also facilitate the endocytosis of plasma membrane proteins to lysosomes for degradation (Hershko and Ciechanover, 1998) . Ubiquitin is a 76 amino acid -1 (Zhang et al., 2000) . Parkin patient with the R275W mutation. Moreover, the reduction in parkin activity can contribute to inclusion formaincreases the degradation of CDCrel-1, while the mutations Q311stop and T415N do not affect turnover.
tion, since synphilin-1, which may induce the formation of ␣-syn aggregates, is a substrate for parkin and thereCDCrel-1 may regulate the functioning of synaptic vesicles, such as transport and release, and it is possible fore may accumulate in cells with reduced parkin activity. that the increased abundance of this protein due to the impairment of parkin may reduce synaptic release, but A more diverse role of parkin is suggested by its increased expression following cellular stress associated this possibility remains to be evaluated.
Synphilin-1, which was identified and cloned as an with the accumulation of unfolded proteins (Imai et al., 2000) . Parkin can assist in the removal of misfolded ␣-syn-interacting protein, also is a substrate for parkintargeted ubiquitination (Chung et al., 2001) . The function proteins in the endoplasmic reticulum (ER), as demonstrated for a homolog of endothelin receptor type B, of synphilin-1 is unknown, but it is present in LBs, and and it is possible that it can also be sequestered into other types of pathological inclusions that share structural similarities to nigral LBs. The redistribution of parkin or other E3 ligases into proteinaceous inclusions may be a common pathological mechanism.
The identification and characterization of defective genes involved in the inherited forms of PD revealed some of the primary causes of these disorders, but they also provide insights into the biochemical pathways that may also be involved in the sporadic forms of the disease. The wide range in the age of presentation, even in some patients with the same gene defect, suggests that other contributors, either modulatory genes or environmental factors, are involved in the pathobiology of PD.
